Study of a Flu Vaccine in Children
Launched by NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID) · Aug 30, 2001
Trial Information
Current as of May 12, 2025
Completed
Keywords
ClinConnect Summary
This is a Phase III trial (an advanced study with a large number of patients). Your child will receive a single dose of flu vaccine, which is given by a nasal spray.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- Your child may be eligible for this study if he/she:
- • Is between the ages of 18 months and 18 years, with consent of parent or guardian.
- • Is a resident of the Temple-Belton, Texas area.
- Exclusion Criteria:
- Your child will not be eligible for this study if he/she:
- • Has had a fever within 3 days before vaccination.
- • Has symptoms of a weakened immune system.
- • Has had a wheezing episode within the past 2 weeks.
- • Has moderate to severe asthma.
- • Is allergic to eggs.
- • Needs to take aspirin on a regular basis.
- • Has received another vaccine or study drug in the past month.
About National Institute Of Allergy And Infectious Diseases (Niaid)
The National Institute of Allergy and Infectious Diseases (NIAID) is a key component of the National Institutes of Health (NIH) dedicated to advancing the understanding, prevention, and treatment of infectious and immune-mediated diseases. Through rigorous clinical trials, NIAID aims to foster innovative research that enhances public health and addresses global health challenges, including emerging infectious diseases and allergies. The institute collaborates with various partners, including academic institutions, industry, and international organizations, to translate scientific discoveries into effective therapies and vaccines. NIAID's commitment to high-quality clinical research is integral to improving health outcomes and informing policy decisions in the realm of infectious diseases and immunology.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials